Obese Clinical Trials

80 recruitingLast updated: June 18, 2026

There are 80 actively recruiting obese clinical trials across 29 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include San Antonio, Texas, United States, Miami, Florida, United States, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Obese Trials at a Glance

80 actively recruiting trials for obese are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 36 trials, with the heaviest enrollment activity in San Antonio, Miami, and Dallas. Lead sponsors running obese studies include BrightGene Bio-Medical Technology Co., Ltd., Hanmi Pharmaceutical Company Limited, and University of Avignon.

Treatments under study

About Obese Clinical Trials

Looking for clinical trials for Obese? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obese trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obese clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 80 trials

Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting
Phase 1Phase 2

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)Obese or Overweight Healthy Volunteers
Alnylam Pharmaceuticals144 enrolled22 locationsNCT06845202
Recruiting
Not Applicable

Effect of Combined Resisted Training and Protein-based Diet on Frailty in Sarcopenic Elderly Women

ObeseSarcopenic Obesity
Cairo University60 enrolled1 locationNCT07627919
Recruiting
Phase 2

EXploratory Study on Postprandial Energy Metabolism

Obesity and OverweightModerately Obese
Lallemand Health Solutions66 enrolled1 locationNCT06786052
Recruiting
Phase 1

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc.180 enrolled2 locationsNCT07399678
Recruiting
Not Applicable

Time-Restricted Eating for Weight-Loss Maintenance

Overweight or Obese Adults
Harbin Medical University500 enrolled10 locationsNCT07163455
Recruiting

Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function

Obesity, ChildhoodType 2 Diabetes Mellitus in Obese
Philippe Klee, MD-PhD50 enrolled1 locationNCT06682481
Recruiting
Phase 1Phase 2

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Obese AdolescentsOverweight Adolescents
Texas Tech University30 enrolled1 locationNCT06755827
Recruiting
Not Applicable

Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial

Overweight or obeseCHD
Guangdong Provincial People's Hospital140 enrolled1 locationNCT07514611
Recruiting
Not Applicable

Study of the Effect of Capsinoid Supplementation on Brown Adipose Tissue in Obese Adolescents

ExerciseObese AdolescentsDiet Modification+1 more
University of Avignon38 enrolled1 locationNCT06916208
Recruiting
Not Applicable

Exercise-snacks for Breaking the Sedentary Lifestyle and Improving the Physical Fitness of Obese Adolescents?

ExerciseObese AdolescentsSedentary Time
University of Avignon48 enrolled2 locationsNCT06626295
Recruiting
Phase 1

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

ObesityObese
Hanmi Pharmaceutical Company Limited90 enrolled1 locationNCT07219589
Recruiting
Not Applicable

Stable Isotopes- Adults With Obesity

Protein metabolismGlucose metabolismObese Patients (BMI ≥ 30 kg/m²)
University of Illinois at Urbana-Champaign8 enrolled1 locationNCT07020741
Recruiting
Phase 1

A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

HealthyOverweight and Obese Adults
Syntis Bio64 enrolled1 locationNCT07307274
Recruiting

Pregnancy Cohort Study: Pregnancy as a Window to Future Health

healthy pregnant womenGestational DiabetesObese pregnant women
Medical University of Graz800 enrolled1 locationNCT06925815
Recruiting
Phase 1

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

OverweightObese
Novo Nordisk A/S100 enrolled1 locationNCT07411560
Recruiting
Phase 1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

Obese But Otherwise Healthy Participants
Corbus Pharmaceuticals Inc.252 enrolled15 locationsNCT07310901
Recruiting
Not Applicable

Comparison of Airway Ultrasonography and Laryngoscopy Methods in Obese Patients

Correlation of Difficult Airway Markers With Ultrasonographic Measurements in Obese Patients
Trabzon Kanuni Education and Research Hospital180 enrolled1 locationNCT07482436
Recruiting
Not Applicable

The Metabolic Effects of Oral Tributyrin Administration

Healthy Overweight/Obese
University of Aarhus12 enrolled1 locationNCT07463495
Recruiting
Not Applicable

Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients

Esophageal CancerGastric CancerHypoxemia+1 more
Zhejiang University410 enrolled5 locationsNCT07175155